Company leaders said their platform addresses challenges facing CRISPR researchers, such as access to bioinformatics experts and the implementation of cloud resources.

Through the platform, researchers can store, transform, and visualize their data without writing any code. Files can be imported from existing data stacks, and users can further interrogate results using the built-in genomic visualizer and quality controls. Latch's platform is free to academic research users, the company said.

Funding was led by Lux Capital with participation from General Catalyst, Haystack, Fifty Years, and Asimov co-founder and CEO, Alec Nielsen, PhD.